Skip to Main Content

Author Details

Alicia Y Zhou
University of California san francisco
2007
37
23
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36623239Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.JCO Precis Oncol2023
35013591Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.Nat Microbiol2022
35346344Whole-genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program.Genome Med2022
33310085Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction Study.Gastroenterology2021
34518375Model-driven mitigation measures for reopening schools during the COVID-19 pandemic.Proc Natl Acad Sci U S A2021
34625409Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.Cancer Prev Res (Phila)2021
31630993Ethnic disparities among men with prostate cancer undergoing germline testing.Urol Oncol2020
31871109Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon.Cancer Epidemiol Biomarkers Prev2020
33181822Color Data v2: a user-friendly, open-access database with hereditary cancer and hereditary cardiovascular conditions datasets.Database (Oxford)2020
32820175Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions.Nat Commun2020
32143996Patient acceptance of genetic testing for familial hypercholesterolemia in the CASCADE FH Registry.J Clin Lipidol2020
32255556Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.Cancer Med2020
32160543MYC Dysregulates Mitosis, Revealing Cancer Vulnerabilities.Cell Rep2020
30759220A scalable, aggregated genotypic-phenotypic database for human disease variation.Database (Oxford)2019
31771638Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores.Genome Med2019
30239769Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.J Natl Cancer Inst2019
29804199Identification of a novel GREM1 duplication in a patient with multiple colon polyps.Fam Cancer2019
31201024Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.J Mol Diagn2019
29665779A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing.BMC Genomics2018
30397354Cancer cells exploit an orphan RNA to drive metastatic progression.Nat Med2018
30588330Rare <i>TP53</i> variant associated with Li-Fraumeni syndrome exhibits variable penetrance in a Saudi family.NPJ Genom Med2018
28716678Cancer recurrence monitoring using hyperpolarized [1-<sup>13</sup>C]pyruvate metabolic imaging in murine breast cancer model.Magn Reson Imaging2017
28828701Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel.Breast Cancer Res Treat2017
26950360Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.Nat Med2016
27775705PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression.Nat Med2016
24362534TRAF2 is an NF-κB-activating oncogene in epithelial cancers.Oncogene2015
26472073Multiple breast cancer risk variants are associated with differential transcript isoform expression in tumors.Hum Mol Genet2015
26416748Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.Nature2015
25501949Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map.Cancer Discov2015
23453969IKKε-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex.Cell Rep2013
24137534A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis.Elife2013
23453972Structure and ubiquitination-dependent activation of TANK-binding kinase 1.Cell Rep2013
23007157IκB kinase ε phosphorylates TRAF2 to promote mammary epithelial cell transformation.Mol Cell Biol2012
20713713Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.Proc Natl Acad Sci U S A2010
19481526Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.Mol Cell2009
18485877The epithelial-mesenchymal transition generates cells with properties of stem cells.Cell2008
17537911Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers.Proc Natl Acad Sci U S A2007
  • 1 - 37 of 37

Recommended Authors

Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 3
Brigham Young University
Career Start Year 2008
Number of shared co-authors 0
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 2
University of California San Diego
Career Start Year 2008
Number of shared co-authors 5
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 4
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 2
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 6
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 5
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 4
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 1
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 5
Washington University
Career Start Year 2003
Number of shared co-authors 7
University of California
Career Start Year 2003
Number of shared co-authors 5
Washington University
Career Start Year 2003
Number of shared co-authors 4
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 5
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 8
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 0
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 1
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 5
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 5
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 5
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 8
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 5
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 7
University of California los angeles
Career Start Year 1991
Number of shared co-authors 3
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year 1986
Number of shared co-authors 6

Collaborators

University of California San Francisco
Co-authored papers 9
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers 5
Invitae Corporation
Co-authored papers 3
Co-authored papers 3
Fred Hutchinson Cancer Research Center
Co-authored papers 3
Co-authored papers 3
University of California San Francisco
Co-authored papers 2
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 2
Integrated Graduate School of Medicine, University of Yamanashi
Co-authored papers 2
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 2
Argonne National Laboratory
Co-authored papers 1
Walter and Eliza Hall Institute of Medical Research
Co-authored papers 1
Broad Institute
Co-authored papers 1
University of California berkeley
Co-authored papers 1
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Leibniz Institute for Immunotherapy (LIT)
Co-authored papers 1
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 1
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Center for the Science of Therapeutics, Broad Institute
Co-authored papers 1
Center for Inherited Disease Research, Johns Hopkins School of Medicine
Co-authored papers 1
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
University of Washington and Fred Hutchinson Cancer Research Center
Co-authored papers 1
Center for Computational Health
Co-authored papers 1
University of California-San Francisco
Co-authored papers 1